Approaches necessary to implement early diagnosis ortargeted therapies for osteoporosis still need to be developed.The task is complicated by experimental data frommethylome studies, in which genes other than critical regulatoryfactors, such as RUNX2, sclerostin or DKK1, wereobserved to be key and most important. This evidence concerns the gene RUNX2 and osteoporosis.